Christopher A. Boerner
2014
In 2014, Christopher A. Boerner earned a total compensation of $2.4M as Former EVP, Commercial at Seattle Genetics, a 35% increase compared to previous year.
Compensation breakdown
| Option Awards | $747,598 |
|---|---|
| Salary | $408,133 |
| Stock Awards | $1,228,140 |
| Other | $9,087 |
| Total | $2,392,958 |
Boerner received $1.2M in stock awards, accounting for 51% of the total pay in 2014.
Boerner also received $747.6K in option awards, $408.1K in salary and $9.1K in other compensation.
Rankings
In 2014, Christopher A. Boerner's compensation ranked 3,826th out of 13,032 executives tracked by ExecPay. In other words, Boerner earned more than 70.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,826 out of 13,032 | 71st |
Division Manufacturing | 1,350 out of 4,965 | 73rd |
Major group Chemicals And Allied Products | 436 out of 1,690 | 74th |
Industry group Drugs | 338 out of 1,369 | 75th |
Industry Biological Products, Except Diagnostic Substances | 54 out of 241 | 78th |
Source: SEC filing on April 6, 2015.
Boerner's colleagues
We found five more compensation records of executives who worked with Christopher A. Boerner at Seattle Genetics in 2014.
2014
Clay Siegall
Seattle Genetics
Chief Executive Officer
2014
Jonathan Drachman
Seattle Genetics
Chief Medical Officer
2014
Eric Dobmeier
Seattle Genetics
Chief Operating Officer
2014
Todd Simpson
Seattle Genetics
Chief Financial Officer
2014
Vaughn Himes
Seattle Genetics